pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection
Authors:
Huiming Xia,
My Hoang,
Evelyn Schmidt,
Susanna Kiwala,
Joshua McMichael,
Zachary L. Skidmore,
Bryan Fisk,
Jonathan J. Song,
Jasreet Hundal,
Thomas Mooney,
Jason R. Walker,
S. Peter Goedegebuure,
Christopher A. Miller,
William E. Gillanders,
Obi L. Griffith,
Malachi Griffith
Abstract:
Neoantigen targeting therapies including personalized vaccines have shown promise in the treatment of cancers. Accurate identification/prioritization of neoantigens is highly relevant to designing clinical trials, predicting treatment response, and understanding mechanisms of resistance. With the advent of massively parallel sequencing technologies, it is now possible to predict neoantigens based…
▽ More
Neoantigen targeting therapies including personalized vaccines have shown promise in the treatment of cancers. Accurate identification/prioritization of neoantigens is highly relevant to designing clinical trials, predicting treatment response, and understanding mechanisms of resistance. With the advent of massively parallel sequencing technologies, it is now possible to predict neoantigens based on patient-specific variant information. However, numerous factors must be considered when prioritizing neoantigens for use in personalized therapies. Complexities such as alternative transcript annotations, various binding, presentation and immunogenicity prediction algorithms, and variable peptide lengths/registers all potentially impact the neoantigen selection process. While computational tools generate numerous algorithmic predictions for neoantigen characterization, results from these pipelines are difficult to navigate and require extensive knowledge of the underlying tools for accurate interpretation. Due to the intricate nature and number of salient neoantigen features, presenting all relevant information to facilitate candidate selection for downstream applications is a difficult challenge that current tools fail to address. We have created pVACview, the first interactive tool designed to aid in the prioritization and selection of neoantigen candidates for personalized neoantigen therapies. pVACview has a user-friendly and intuitive interface where users can upload, explore, select and export their neoantigen candidates. The tool allows users to visualize candidates using variant, transcript and peptide information. pVACview will allow researchers to analyze and prioritize neoantigen candidates with greater efficiency and accuracy in basic and translational settings. The application is available as part of the pVACtools pipeline at pvactools.org and as an online server at pvacview.org.
△ Less
Submitted 11 June, 2024;
originally announced June 2024.
Bam-readcount -- rapid generation of basepair-resolution sequence metrics
Authors:
Ajay Khanna,
David E. Larson,
Sridhar Nonavinkere Srivatsan,
Matthew Mosior,
Travis E. Abbott,
Susanna Kiwala,
Timothy J. Ley,
Eric J. Duncavage,
Matthew J. Walter,
Jason R. Walker,
Obi L. Griffith,
Malachi Griffith,
Christopher A. Miller
Abstract:
Bam-readcount is a utility for generating low-level information about sequencing data at specific nucleotide positions. Originally designed to help filter genomic mutation calls, the metrics it outputs are useful as input for variant detection tools and for resolving ambiguity between variant callers . In addition, it has found broad applicability in diverse fields including tumor evolution, singl…
▽ More
Bam-readcount is a utility for generating low-level information about sequencing data at specific nucleotide positions. Originally designed to help filter genomic mutation calls, the metrics it outputs are useful as input for variant detection tools and for resolving ambiguity between variant callers . In addition, it has found broad applicability in diverse fields including tumor evolution, single-cell genomics, climate change ecology, and tracking community spread of SARS-CoV-2. Here we report on the release of version 1.0 of this tool, which adds CRAM support, among other improvements. It is released under a permissive MIT license and available at https://github.com/genome/bam-readcount.
△ Less
Submitted 27 July, 2021;
originally announced July 2021.
